BRRN (BRRN) 10-K & 8-K - SEC Filings AI Analysis

Current Report Filed: 2026-05-11

MEDO Healthcare LLC acquired 84.7% voting control of Bryn Inc. by purchasing 10 million Series A-1 Preferred Shares for only $175,000, representing an extreme valuation discount and indicating severe financial distress or a restructuring transaction.
Complete management change occurred with founder David Lazar resigning as sole director and officer, replaced by John Leo (CEO) and Arthur Magee (CFO/Secretary), suggesting strategic repositioning under new leadership with significant financial services and investment banking experience.
The transaction reflects a change of control event where voting power shifted dramatically from Lazar (previously sole control) to MEDO Healthcare (84.7% voting power), with actual operational control held by Miriam Mizrachi as Manager of Ashford Capital LLC.
John Leo's appointment as CEO brings extensive experience in investment banking, M&A, and capital markets across 100+ U.S. and 50+ foreign companies, along with recent executive experience at a financial institution, suggesting potential strategic repositioning or acquisition activity ahead.

Annual Report Filed: 2026-04-02

Byrn, Inc. (BRRN) appears to be a shell company with no active business operations as of December 31, 2025.
The company has not filed any reports required under Section 13 or 15(d) of the Exchange Act in the past 12 months.
Byrn, Inc. has not submitted any Interactive Data Files as required by Regulation S-T in the past 12 months.

BRRN (BRRN)